DK1469859T3 - Anvendelse af flerumættede ketoner til behandling af psoriasis - Google Patents

Anvendelse af flerumættede ketoner til behandling af psoriasis

Info

Publication number
DK1469859T3
DK1469859T3 DK03704739.6T DK03704739T DK1469859T3 DK 1469859 T3 DK1469859 T3 DK 1469859T3 DK 03704739 T DK03704739 T DK 03704739T DK 1469859 T3 DK1469859 T3 DK 1469859T3
Authority
DK
Denmark
Prior art keywords
psoriasis
treatment
group
hydrocarbon group
polyunsaturated ketones
Prior art date
Application number
DK03704739.6T
Other languages
English (en)
Inventor
Berit Johansen
Marit Anthonsen
Wenche Sjursen
Anne Kristen Holmeide
Lars Skattebol
Original Assignee
Avexxin As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avexxin As filed Critical Avexxin As
Application granted granted Critical
Publication of DK1469859T3 publication Critical patent/DK1469859T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03704739.6T 2002-01-29 2003-01-29 Anvendelse af flerumættede ketoner til behandling af psoriasis DK1469859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0202002.2A GB0202002D0 (en) 2002-01-29 2002-01-29 Use
PCT/GB2003/000364 WO2003063878A1 (en) 2002-01-29 2003-01-29 Use of polyunsaturated ketones for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
DK1469859T3 true DK1469859T3 (da) 2012-03-19

Family

ID=9929945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03704739.6T DK1469859T3 (da) 2002-01-29 2003-01-29 Anvendelse af flerumættede ketoner til behandling af psoriasis

Country Status (14)

Country Link
US (4) US7687543B2 (da)
EP (1) EP1469859B1 (da)
JP (1) JP4608214B2 (da)
KR (1) KR100874505B1 (da)
CN (2) CN101849929A (da)
AT (1) ATE535245T1 (da)
AU (1) AU2003206999B2 (da)
CA (1) CA2473687C (da)
DK (1) DK1469859T3 (da)
ES (1) ES2378303T3 (da)
GB (1) GB0202002D0 (da)
NO (1) NO334413B1 (da)
PT (1) PT1469859E (da)
WO (1) WO2003063878A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248798A1 (en) * 2009-05-08 2010-11-10 Pronova BioPharma Norge AS Novel lipid compounds
GB0909643D0 (en) 2009-06-04 2009-07-22 Avexxin As Glomerulonephritis treatment
CN103772312B (zh) * 2009-10-02 2016-08-17 埃维克辛公司 抗炎症的2-羰基噻唑和2-羰基恶唑
GB201014633D0 (en) 2010-09-02 2010-10-13 Avexxin As Rheumatoid arthritis treatment
SG10201509127YA (en) 2010-11-05 2015-12-30 Pronova Biopharma Norge As Methods of treatment using lipid compounds
GB201205394D0 (en) 2012-03-27 2012-05-09 Adlens Ltd Improvements in or relating to deformable non-round membrane assemblies
GB201221329D0 (en) * 2012-11-27 2013-01-09 Avexxin As Dermatitis treatment
US20150376161A1 (en) 2013-01-29 2015-12-31 Avexxin As Antiiflammatory and antitumor 2-oxothiazoles abd 2-oxothiophenes compounds
US11351139B2 (en) 2013-02-28 2022-06-07 Basf As Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
GB201313238D0 (en) 2013-07-24 2013-09-04 Avexxin As Process for the preparation of a polyunsaturated ketone compound
GB201409363D0 (en) * 2014-05-27 2014-07-09 Avexxin As Skin cancer treatment
GB201413695D0 (en) 2014-08-01 2014-09-17 Avexxin As Compound
GB201501144D0 (en) 2015-01-23 2015-03-11 Avexxin As Process for the preparation of a polyunsaturated ketone compound
AU2016256552B2 (en) 2015-04-28 2021-04-01 Pronova Biopharma Norge As Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
GB201604318D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
CA3025703A1 (en) * 2016-06-03 2017-12-07 Avexxin As Combination therapy comprising a polyunsaturated ketone and a corticosteroid
GB201609735D0 (en) * 2016-06-03 2016-07-20 Avexxin As Combination therapy
US20200323793A1 (en) * 2016-06-03 2020-10-15 Avexxin As Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
JP2019517525A (ja) * 2016-06-03 2019-06-24 アヴェクシン エーエス 多価不飽和ケトン及びセコステロイドを含む併用療法
CA3037582A1 (en) 2016-09-21 2018-03-29 Avexxin As Pharmaceutical composition
JP7305562B2 (ja) * 2017-06-16 2023-07-10 アヴェクシン エーエス 線維性疾患の治療のための組成物および方法
IL308604B2 (en) 2017-12-06 2025-08-01 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
GB201807892D0 (en) 2018-05-15 2018-06-27 Avexxin As Processes in the preparation of polyunsaturated ketone compounds
GB202020843D0 (en) 2020-12-31 2021-02-17 Coegin Pharma Ab Actinic keratosis treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09268153A (ja) 1996-04-02 1997-10-14 Sagami Chem Res Center トリフルオロメチルケトン誘導体及びホスホリパーゼa2阻害剤
EP1140791A2 (en) * 1997-09-23 2001-10-10 Bristol-Myers Squibb Company Selective cpla 2 inhibitors
JPH11199493A (ja) * 1997-11-13 1999-07-27 Nof Corp 皮膚外用剤組成物
US7605149B1 (en) * 1998-07-13 2009-10-20 University Of South Florida Modulation of the phospholipase A2 pathway as a therapeutic
WO2002060535A1 (en) 2001-01-31 2002-08-08 Leff Alan R Method of treating inflammatory conditions by inhibiting cytosolic phospholipase a¿2?
EP1243524A3 (en) * 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
US20040111957A1 (en) * 2002-12-13 2004-06-17 Filippini Brian B. Water blended fuel composition

Also Published As

Publication number Publication date
US7687543B2 (en) 2010-03-30
KR20040089127A (ko) 2004-10-20
NO20043548L (no) 2004-08-25
CA2473687C (en) 2011-04-12
EP1469859A1 (en) 2004-10-27
KR100874505B1 (ko) 2008-12-18
US8865768B2 (en) 2014-10-21
US20100152293A1 (en) 2010-06-17
WO2003063878A1 (en) 2003-08-07
US8524776B2 (en) 2013-09-03
US20130324613A1 (en) 2013-12-05
US20150202165A1 (en) 2015-07-23
CA2473687A1 (en) 2003-08-07
US9375409B2 (en) 2016-06-28
JP4608214B2 (ja) 2011-01-12
GB0202002D0 (en) 2002-03-13
AU2003206999B2 (en) 2007-12-13
JP2005518419A (ja) 2005-06-23
EP1469859B1 (en) 2011-11-30
PT1469859E (pt) 2012-03-06
CN1678323A (zh) 2005-10-05
CN101849929A (zh) 2010-10-06
ATE535245T1 (de) 2011-12-15
ES2378303T3 (es) 2012-04-11
NO334413B1 (no) 2014-02-24
US20050165116A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
NO20043548L (no) Anvendelse av flerumettede katoner for behandling av psoriasis
SE0301886D0 (sv) New use V
SE0301882D0 (sv) New use I
SE0301888D0 (sv) New use VII
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
DE60231804D1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
ATE440094T1 (de) Fumagillolderivate und verfahren zu deren herstellung
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
DE60231050D1 (de) Verwendung von Totarol zur Behandlung von Pruritus
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
NO20025510D0 (no) Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer
ATE390130T1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
ATE443044T1 (de) Tace inhibitoren
DE60011794D1 (de) Verwendung von docetaxel für die behandlung von hepatozelluläre krebs
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
SE0004101D0 (sv) New use
DE60330864D1 (de) Neue verbindungen, deren verwendung und herstellung
SE0301883D0 (sv) New use II
SE0301885D0 (sv) New use IV
RU2007138263A (ru) Противовоспалительные соединения
DE69324374D1 (de) Verwendung von kardiotonischen Mitteln und Inhibitoren der Stickstoffoxidsynthese zur Linderung von pathologisch verringertem Blutdruck
SE0301884D0 (sv) New use III
WO2003094967A3 (en) New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders